Femasys (FEMY) Net Cash Flow (2020 - 2026)
Femasys' (FEMY) quarterly Net Cash Flow came in at -$3.9 million in Q1 2026, down 1153.15% YoY from $368447.0 in Q1 2025, and down 182.61% on a QoQ basis from $4.7 million in Q4 2025.
Femasys (FEMY) Net Cash Flow (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Net Cash Flow data on file, last reported at -$3.9 million in Q1 2026.
- Quarterly Net Cash Flow fell 1153.15% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 111.17% YoY) and the FY2025 annual result came in at $5.8 million, up 131.84% from the prior year.
- Net Cash Flow retreated to -$3.9 million in Q1 2026, from $4.7 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $13.0 million in Q4 2023 to a low of -$5.9 million in Q3 2024.
- A 5-year average of -$1.1 million and a median of -$2.8 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow soared 527.89% — and 2026, when it sank 1153.15%.
- Tracing FEMY's Net Cash Flow over 5 years: stood at -$3.0 million in 2022, then soared by 527.89% to $13.0 million in 2023, then slumped by 131.94% to -$4.2 million in 2024, then soared by 212.93% to $4.7 million in 2025, then slumped by 182.61% to -$3.9 million in 2026.
- The last three Net Cash Flow figures came in at -$3.9 million (Q1 2026), $4.7 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.61 Bn | 129.40 Bn | 1.96 Bn | 746.50 Mn |
| 2 | Becton Dickinson | 52.47 Bn | 51.61 Bn | 2.32 Bn | -42.00 Mn |
| 3 | Alcon | 35.80 Bn | 34.45 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.87 Bn | 32.41 Bn | 861.22 Mn | -192.18 Mn |
| 5 | Medline | 28.89 Bn | 26.21 Bn | 2.22 Bn | 95.00 Mn |
| 6 | West Pharmaceutical Services | 25.07 Bn | 24.63 Bn | 329.20 Mn | -84.00 Mn |
| 7 | Solventum | 15.33 Bn | 14.92 Bn | 1.29 Bn | -160.00 Mn |
| 8 | Cooper Companies | 14.85 Bn | 14.71 Bn | 735.40 Mn | 17.00 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 149.00 Mn |
| 10 | Femasys | 9.99 Mn | 8.54 Mn | 189,391.00 | -3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.88 Mn |
| Mar 31, 2026 | -3.88 Mn |
| Dec 31, 2025 | 4.70 Mn |
| Dec 31, 2025 | 4.70 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | -602,141.00 |
| Jun 30, 2025 | -602,141.00 |
| Mar 31, 2025 | 368,447.00 |
| Mar 31, 2025 | 368,447.00 |
| Dec 31, 2024 | -4.16 Mn |
| Dec 31, 2024 | -4.16 Mn |
| Sep 30, 2024 | -5.91 Mn |
| Sep 30, 2024 | -5.91 Mn |
| Jun 30, 2024 | -4.31 Mn |
| Jun 30, 2024 | -4.31 Mn |
| Mar 31, 2024 | -3.88 Mn |
| Mar 31, 2024 | -3.88 Mn |
| Dec 31, 2023 | 13.02 Mn |
| Dec 31, 2023 | 13.02 Mn |